Epidermal growth factor (EGF) receptor targeted delivery of PEGylated adenovirus
- 1 February 2008
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 366 (3) , 769-774
- https://doi.org/10.1016/j.bbrc.2007.12.045
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Effective tumor targeted gene transfer using PEGylated adenovirus vector via systemic administrationJournal of Controlled Release, 2007
- Adenoviral vectors—How to use them in cancer gene therapy?Virus Research, 2006
- Epidermal Growth Factor Receptor Targeting in CancerSeminars in Oncology, 2006
- Photochemically enhanced transduction of polymer‐complexed adenovirus targeted to the epidermal growth factor receptorThe Journal of Gene Medicine, 2005
- Targeted Adenovirus VectorsHuman Gene Therapy, 2004
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004
- FGF2-Targeted Adenovirus Encoding Platelet-Derived Growth Factor-B Enhances de Novo Tissue FormationMolecular Therapy, 2000
- Adenovirus complexed with polyethylene glycol and cationic lipid is shielded from neutralizing antibodies in vitroGene Therapy, 1998
- Isolation of a Common Receptor for Coxsackie B Viruses and Adenoviruses 2 and 5Science, 1997
- Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell typesNature Biotechnology, 1996